GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Asset Turnover

Sandoz Group AG (Sandoz Group AG) Asset Turnover : 0.54 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Sandoz Group AG's Revenue for the three months ended in Dec. 2023 was $9,979 Mil. Sandoz Group AG's Total Assets for the quarter that ended in Dec. 2023 was $18,494 Mil. Therefore, Sandoz Group AG's Asset Turnover for the quarter that ended in Dec. 2023 was 0.54.

Asset Turnover is linked to ROE % through Du Pont Formula. Sandoz Group AG's annualized ROE % for the quarter that ended in Dec. 2023 was 3.54%. It is also linked to ROA % through Du Pont Formula. Sandoz Group AG's annualized ROA % for the quarter that ended in Dec. 2023 was 1.67%.


Sandoz Group AG Asset Turnover Historical Data

The historical data trend for Sandoz Group AG's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Asset Turnover Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23
Asset Turnover
0.53 0.54

Sandoz Group AG Quarterly Data
Dec22 Dec23
Asset Turnover 0.53 0.54

Competitive Comparison of Sandoz Group AG's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sandoz Group AG's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's Asset Turnover falls into.



Sandoz Group AG Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Sandoz Group AG's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=9979/( (17557+19430)/ 2 )
=9979/18493.5
=0.54

Sandoz Group AG's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Dec. 2023 ))/ count )
=9979/( (17557+19430)/ 2 )
=9979/18493.5
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Sandoz Group AG  (OTCPK:SDZNY) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Sandoz Group AG's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=308/8696.5
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(308 / 39916)*(39916 / 18493.5)*(18493.5/ 8696.5)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.77 %*2.1584*2.1265
=ROA %*Equity Multiplier
=1.67 %*2.1265
=3.54 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Sandoz Group AG's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=308/18493.5
=(Net Income / Revenue)*(Revenue / Total Assets)
=(308 / 39916)*(39916 / 18493.5)
=Net Margin %*Asset Turnover
=0.77 %*2.1584
=1.67 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Sandoz Group AG Asset Turnover Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Sandoz Group AG (Sandoz Group AG) Business Description

Traded in Other Exchanges
Address
Forum 1, Novartis Campus, Basel, CHE, CH-4056
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research 02-14-2024